meningococcal conjugate vaccine

URI: https://gptkb.org/entity/meningococcal_conjugate_vaccine
GPTKB entity
Statements (42)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:administeredBy intramuscular injection
gptkbp:approvedBy gptkb:FDA
gptkbp:boosterDoseAge 16 years
gptkbp:boosterRecommended high-risk groups
gptkbp:brand gptkb:MenQuadfi
gptkb:Menveo
gptkb:Nimenrix
gptkb:Menactra
gptkbp:broadcastOn 2 doses for adolescents
gptkbp:contains amino acid transporter
polysaccharide antigens
gptkbp:contraindication severe allergic reaction to previous dose
gptkbp:developedBy 2000s
gptkbp:durationOfImmunity 5 years or more
gptkbp:firstDoseAge 11-12 years
https://www.w3.org/2000/01/rdf-schema#label meningococcal conjugate vaccine
gptkbp:includedIn routine immunization schedule in many countries
gptkbp:notProtectAgainst serogroup B
gptkbp:pregnancyCategory consult healthcare provider
gptkbp:prevention meningococcal disease
gptkbp:protectedBy serogroup A
serogroup C
serogroup W
serogroup Y
gptkbp:recommendation adolescents
young adults
people with certain medical conditions
gptkbp:replacedBy meningococcal polysaccharide vaccine
gptkbp:sideEffect fever
fatigue
headache
pain at injection site
gptkbp:storage 2-8°C
gptkbp:target gptkb:Neisseria_meningitidis
gptkbp:usedIn gptkb:Australia
gptkb:Canada
gptkb:Europe
gptkb:United_States
gptkbp:WHOStatus gptkb:World_Health_Organization_Model_List_of_Essential_Medicines
gptkbp:bfsParent gptkb:CRM197
gptkbp:bfsLayer 6